| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Aug 16, 2023 | Taysha Gene Therapies, Inc. | Director | Buy | 97.5 | +827,778 | 74.85% | ✗ | $700K |
| Jul 5, 2022 | Jul 5, 2022 | Verrica Pharmaceuticals Inc. | Director | Buy | 97.5 | +238,095 | 51.52% | ✗ | $500K |
| Jul 6, 2021 | Jul 8, 2021 | Acumen Pharmaceuticals, Inc. | Director | Buy | 97.5 | +35,000 | 25.49% | ✗ | $560K |
| Aug 13, 2020 | Aug 17, 2020 | Verrica Pharmaceuticals Inc. | Director | Buy | 90.0 | +31,250 | 7.25% | ✗ | $200.5K |
| Jan 7, 2019 | Jan 7, 2019 | Verrica Pharmaceuticals Inc. | Director | Buy | 82.5 | +9,221 | 2.19% | ✗ | $96.4K |